These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31230613)

  • 1. Using the genetic characteristics of Neisseria gonorrhoeae strains with decreased susceptibility to cefixime to develop a molecular assay to predict cefixime susceptibility.
    Deng X; Allan-Blitz LT; Klausner JD
    Sex Health; 2019 Sep; 16(5):488-499. PubMed ID: 31230613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae.
    Takahata S; Senju N; Osaki Y; Yoshida T; Ida T
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3638-45. PubMed ID: 16940068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loop-Mediated Isothermal Amplification Assay for Identifying Neisseria gonorrhoeae Nonmosaic
    Shimuta K; Takahashi H; Akeda Y; Nakayama SI; Ohnishi M
    Microbiol Spectr; 2022 Oct; 10(5):e0233522. PubMed ID: 36000906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unique combined penA/mtrR/porB mutations and NG-MAST strain types associated with ceftriaxone and cefixime MIC increases in a 'susceptible' Neisseria gonorrhoeae population.
    Thakur SD; Starnino S; Horsman GB; Levett PN; Dillon JR
    J Antimicrob Chemother; 2014 Jun; 69(6):1510-6. PubMed ID: 24532681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence and Spread of Neisseria gonorrhoeae Isolates With Decreased Susceptibility to Extended-Spectrum Cephalosporins in Argentina, 2009 to 2013.
    Gianecini R; Romero MLM; Oviedo C; Vacchino M; Galarza P;
    Sex Transm Dis; 2017 Jun; 44(6):351-355. PubMed ID: 28499284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime.
    Ameyama S; Onodera S; Takahata M; Minami S; Maki N; Endo K; Goto H; Suzuki H; Oishi Y
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3744-9. PubMed ID: 12435671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neisseria gonorrhoeae and extended-spectrum cephalosporins in California: surveillance and molecular detection of mosaic penA.
    Gose S; Nguyen D; Lowenberg D; Samuel M; Bauer H; Pandori M
    BMC Infect Dis; 2013 Dec; 13():570. PubMed ID: 24305088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone.
    Osaka K; Takakura T; Narukawa K; Takahata M; Endo K; Kiyota H; Onodera S
    J Infect Chemother; 2008 Jun; 14(3):195-203. PubMed ID: 18574654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure.
    Unemo M; Golparian D; Nicholas R; Ohnishi M; Gallay A; Sednaoui P
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1273-80. PubMed ID: 22155830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes.
    Limnios A; Tapsall J; Kahlmeter J; Hogan T; Ray S; Lam A; Unemo M
    APMIS; 2011 Jun; 119(6):356-63. PubMed ID: 21569093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA.
    Lindberg R; Fredlund H; Nicholas R; Unemo M
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2117-22. PubMed ID: 17420216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.
    Lee SG; Lee H; Jeong SH; Yong D; Chung GT; Lee YS; Chong Y; Lee K
    J Antimicrob Chemother; 2010 Apr; 65(4):669-75. PubMed ID: 20093260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan.
    Ito M; Deguchi T; Mizutani KS; Yasuda M; Yokoi S; Ito S; Takahashi Y; Ishihara S; Kawamura Y; Ezaki T
    Antimicrob Agents Chemother; 2005 Jan; 49(1):137-43. PubMed ID: 15616287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neisseria gonorrhoeae Antimicrobial Susceptibility Surveillance - The Gonococcal Isolate Surveillance Project, 27 Sites, United States, 2014.
    Kirkcaldy RD; Harvey A; Papp JR; Del Rio C; Soge OO; Holmes KK; Hook EW; Kubin G; Riedel S; Zenilman J; Pettus K; Sanders T; Sharpe S; Torrone E
    MMWR Surveill Summ; 2016 Jul; 65(7):1-19. PubMed ID: 27414503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Neisseria gonorrhoeae isolates from Hefei (2014-2015): genetic characteristics of antimicrobial resistance.
    Jiang FX; Lan Q; Le WJ; Su XH
    BMC Infect Dis; 2017 May; 17(1):366. PubMed ID: 28545411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence and Spread of Cephalosporin-Resistant Neisseria gonorrhoeae with Mosaic penA Alleles, South Korea, 2012-2017.
    Lee H; Suh YH; Lee S; Kim YK; Han MS; Bae HG; Unemo M; Lee K
    Emerg Infect Dis; 2019 Mar; 25(3):416-424. PubMed ID: 30789143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance and molecular characterisation of Neisseria gonorrhoeae isolates in Fukuoka, Japan, 1996-2016.
    Tanaka M; Furuya R; Kobayashi I; Kanesaka I; Ohno A; Katsuse AK
    J Glob Antimicrob Resist; 2019 Jun; 17():3-7. PubMed ID: 30448519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.
    Martin I; Sawatzky P; Allen V; Hoang L; Lefebvre B; Mina N; Wong T; Gilmour M
    Sex Transm Dis; 2012 Apr; 39(4):316-23. PubMed ID: 22421701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
    Kovari H; de Melo Oliveira MD; Hauser P; Läuchli S; Meyer J; Weber R; Zbinden R
    BMC Infect Dis; 2013 Dec; 13():603. PubMed ID: 24369054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial susceptibility and penicillin-binding protein 1 and 2 mutations in Neisseria gonorrhoeae isolated from male urethritis in Sapporo, Japan.
    Takahashi S; Kurimura Y; Hashimoto J; Uehara T; Hiyama Y; Iwasawa A; Nishimura M; Sunaoshi K; Takeda K; Suzuki N; Tsukamoto T
    J Infect Chemother; 2013 Feb; 19(1):50-6. PubMed ID: 22797875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.